First-in-class oral selective SMARCA2 (BRM) inhibitor, FHD-909 (LY4050784), advancing in Phase 1 trial for SMARCA4 mutated cancers,...
Year: 2025
Jamie Dimon, the CEO of banking behemoth JPMorgan, reiterated his critical stance on Bitcoin BTC/USD while recognizing...
By Bhanvi Satija and Puyaan Singh (Reuters) -Johnson & Johnson (JNJ) said on Monday it will buy...
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab...
(Reuters) -Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption...
By Nicole Jao NEW YORK (Reuters) – Investors are souring on the U.S. oil refining sector, citing...
The CNN Money Fear and Greed index showed further decline in overall market sentiment, while the index...
(Reuters) – A look at the day ahead in U.S. and global markets from Mike Dolan Wall...
Electric vehicle (EV) maker Lucid Group (NASDAQ: LCID) reported some good news recently; vehicle production and deliveries...
BEIJING (AP) — Sales of all types of electric vehicles rose more than 40% in China last...
